News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
398,077 Results
Type
Article (15521)
Company Profile (119)
Press Release (382432)
Multimedia
Podcasts (51)
Webinars (9)
Section
Business (118008)
Career Advice (547)
Deals (20221)
Drug Delivery (45)
Drug Development (34104)
Employer Resources (55)
FDA (9277)
Job Trends (8114)
News (183382)
Policy (13301)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1391)
Accelerated approval (11)
Allergies (79)
Alliances (35915)
ALS (58)
Alzheimer's disease (672)
Antibody-drug conjugate (ADC) (187)
Approvals (9487)
Artificial intelligence (464)
Autoimmune disease (72)
Automation (32)
Bankruptcy (140)
Best Places to Work (6876)
BIOSECURE Act (7)
Biosimilars (37)
Biotechnology (89)
Bladder cancer (64)
Brain cancer (32)
Breast cancer (285)
Cancer (2372)
Cardiovascular disease (161)
Career advice (480)
Career pathing (9)
CAR-T (219)
CDC (9)
Cell therapy (527)
Cervical cancer (21)
Clinical research (28527)
Collaboration (1277)
Compensation (301)
Complete response letters (10)
COVID-19 (1276)
CRISPR (85)
C-suite (497)
Cystic fibrosis (82)
Data (2927)
Decentralized trials (1)
Denatured (27)
Depression (48)
Diabetes (218)
Diagnostics (5342)
Digital health (38)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (179)
Drug pricing (22)
Drug shortages (4)
Duchenne muscular dystrophy (93)
Earnings (43638)
Editorial (10)
Employer branding (10)
Employer resources (50)
Events (57116)
Executive appointments (568)
FDA (11015)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (9)
Funding (935)
Gene editing (172)
Generative AI (43)
Gene therapy (361)
GLP-1 (320)
Government (1374)
Grass and pollen (3)
Guidances (234)
Healthcare (10497)
HIV (25)
Huntington's disease (13)
IgA nephropathy (33)
Immunology and inflammation (83)
Immuno-oncology (22)
Indications (51)
Infectious disease (1420)
Inflammatory bowel disease (84)
Inflation Reduction Act (6)
Influenza (75)
Intellectual property (161)
Interviews (63)
IPO (9021)
IRA (10)
Job creations (1507)
Job search strategy (417)
JPM (21)
Kidney cancer (6)
Labor market (24)
Layoffs (137)
Leadership (7)
Legal (2727)
Liver cancer (44)
Longevity (6)
Lung cancer (265)
Lymphoma (192)
Machine learning (36)
Management (19)
Manufacturing (542)
MASH (41)
Medical device (11987)
Medtech (12037)
Mergers & acquisitions (11913)
Metabolic disorders (422)
Multiple sclerosis (86)
NASH (3)
Neurodegenerative disease (133)
Neuropsychiatric disorders (21)
Neuroscience (1193)
NextGen: Class of 2026 (3725)
Non-profit (1692)
Now hiring (15)
Obesity (150)
Opinion (105)
Ovarian cancer (104)
Pain (112)
Pancreatic cancer (111)
Parkinson's disease (125)
Partnered (21)
Patents (315)
Patient recruitment (257)
Peanut (35)
People (34830)
Pharmaceutical (21)
Pharmacy benefit managers (3)
Phase 1 (10215)
Phase 2 (12780)
Phase 3 (8489)
Pipeline (2838)
Policy (63)
Postmarket research (596)
Preclinical (4537)
Press Release (66)
Prostate cancer (104)
Psychedelics (11)
Radiopharmaceuticals (185)
Rare diseases (344)
Real estate (3507)
Recruiting (26)
Regulatory (11167)
Reports (20)
Research institute (1368)
Resumes & cover letters (99)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (36)
Series A (169)
Series B (115)
Service/supplier (6)
Sickle cell disease (39)
Special edition (1)
Spinal muscular atrophy (65)
Sponsored (21)
Startups (2589)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (512)
Venture capital (44)
Weight loss (53)
Women's health (48)
Worklife (2)
Date
Today (99)
Last 7 days (344)
Last 30 days (1206)
Last 365 days (15849)
2026 (1650)
2025 (16147)
2024 (19899)
2023 (23439)
2022 (32252)
2021 (34143)
2020 (32220)
2019 (27220)
2018 (20509)
2017 (19714)
2016 (18470)
2015 (21665)
2014 (15981)
2013 (13377)
2012 (14524)
2011 (14961)
2010 (13644)
Location
Africa (342)
Alabama (71)
Alaska (6)
Arizona (181)
Arkansas (10)
Asia (25584)
Australia (4437)
California (5817)
Canada (1898)
China (577)
Colorado (310)
Connecticut (250)
Delaware (146)
Europe (53030)
Florida (966)
Georgia (228)
Hawaii (2)
Idaho (34)
Illinois (496)
India (34)
Indiana (277)
Iowa (8)
Japan (281)
Kansas (101)
Kentucky (17)
Louisiana (18)
Maine (22)
Maryland (756)
Massachusetts (3976)
Michigan (276)
Minnesota (423)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (16)
Nevada (54)
New Hampshire (83)
New Jersey (1656)
New Mexico (18)
New York (1503)
North Carolina (784)
North Dakota (9)
Northern California (2553)
Ohio (187)
Oklahoma (16)
Oregon (25)
Pennsylvania (1059)
Puerto Rico (19)
Rhode Island (34)
South America (534)
South Carolina (60)
South Dakota (1)
Southern California (2448)
Tennessee (107)
Texas (987)
United States (21311)
Utah (221)
Vermont (1)
Virginia (100)
Washington D.C. (19)
Washington State (527)
West Virginia (3)
Wisconsin (91)
Wyoming (2)
398,077 Results for "hutchinson technology incorporated".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hollister Incorporated Awarded Multiple Contract Agreements with Premier, Inc.
January 20, 2026
·
3 min read
Press Releases
Hutchinson-Gilford Syndrome Market Expected to Grow at a CAGR of 6.59% During 2025-2035, Impelled by Rising Awareness of Rare Genetic Diseases
January 31, 2025
·
9 min read
Biotech Bay
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it and its partner AnGes, Inc. received marketing approval from the Ministry of Health, Labour and Welfare for Zokinvy (lonafarnib), a treatment for Hutchinson-Gilford progeria syndrome (HGPS) and processing deficient progeroid laminopathy (PDPL).
January 18, 2024
·
6 min read
Press Releases
Zomedica Announces “Fourth Friday at Four” Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth
January 14, 2026
·
6 min read
Press Releases
PharmAla Incorporates Australian Entity for Clinical Research
September 4, 2025
·
4 min read
Press Releases
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
November 24, 2025
·
3 min read
Press Releases
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
February 4, 2026
·
4 min read
Press Releases
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
December 17, 2025
·
5 min read
Press Releases
Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease
November 4, 2025
·
5 min read
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
1 of 39,808
Next
